SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

535

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

December 31, 2005

Conditions
Schizophrenic Disorder
Interventions
DRUG

Seroquel Sustained Release (SR)

DRUG

Seroquel Immediate Release (IR)

DRUG

Placebo

Trial Locations (31)

Unknown

Research Site, Burgas

Research Site, Rousse

Research Site, Sofia

Research Site, Sofia- Novi Iskar

Research Site, Athens

Research Site, Chania

Research Site, Corfu

Research Site, Thessaloniki

Research Site, Chennai

Research Site, Karnataka

Research Site, Lucknow

Research Site, New Delhi

Research Site, Jakarta

Research Site, Bandung

Research Site, Surabaya

Research Site, Cebu

Research Site, Davao City

Research Site, Mandaluyong

Research Site, Manila

Research Site, Pasig

Research Site, Brasov

Research Site, Bucharest

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Johannesburg

Research Site, Medunsa

Research Site, Bloemfontein

Research Site, Ga-Rankuwa

Research Site, Johannesburg

Research Site, Lyttelton Manor

Research Site, Pretoria

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY